Liu, Geoffrey
17 papers on CoChatORCID 0000-0002-2603-7296
Most cited papers
- Verified
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 1,495
- Verified
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature
Genetic Associations and EpidemiologySmoking Behavior and Cessation
Cited by 1,275
- Verified
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shen, S. Y., Singhania, R., Fehringer, G., Chakravarthy, A., Roehrl, M. H. A., Chadwick, D., Zuzarte, P. C., Borgida, A., Wang, T. T., Li, T., et al. (2018) · Nature
Cancer Genomics and DiagnosticsEpigenetics and DNA Methylation
Cited by 983
- Verified
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., Riely, G. J., et al. (2016) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 471
- Verified
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Ahn, M.-J., Tanaka, K., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo, M., Pérol, M., et al. (2025) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 244
- Verified
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)
Labbé, C., Cabanero, M., Korpanty, G. J., Tomasini, P., Doherty, M. K., Mascaux, C., Jao, K., Pitcher, B., Wang, R., Pintilie, M., et al. (2017) · Lung Cancer
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 230
- Verified
Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer Consortium
Truong, T., Hung, R. J., Amos, C. I., Wu, X., Bickeböller, H., Rosenberger, A., Sauter, W., Illig, T., Wichmann, H.-E., Risch, A., et al. (2010) · JNCI: Journal of the National Cancer Institute
Genetic Associations and EpidemiologyLung Cancer Research Studies
Cited by 194
- Verified
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization
Zhou, W., Liu, G., Hung, R. J., Haycock, P. C., Aldrich, M. C., Andrew, A. S., Arnold, S. M., Bickeböller, H., Bojesen, S. E., Brennan, P., et al. (2021) · International Journal of Cancer
Genetic Associations and EpidemiologyCancer Risks and Factors
Cited by 172
- Verified
Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals
Lips, E. H., Gaborieau, V., McKay, J. D., Chabrier, A., Hung, R. J., Boffetta, P., Hashibe, M., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., et al. (2010) · International Journal of Epidemiology
Smoking Behavior and CessationGenetic Associations and Epidemiology
Cited by 145
- Verified
Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis
Chow, R., Midroni, J., Kaur, J., Boldt, G., Liu, G., Eng, L., Liu, F.-F., Haibe-Kains, B., Lock, M., & Raman, S. (2023) · JNCI: Journal of the National Cancer Institute
Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare
Cited by 65
- Verified
Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST
Pérol, M., Li, W., Pennell, N. A., Liu, G., Ohe, Y., De Braud, F., Nagasaka, M., Felip, E., Xiong, A., Zhang, Y., et al. (2025) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 63
- Verified
Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial.
Kim, D.-W., Mehra, R., Tan, D. S.-W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J. F., Sharma, S., De Pas, T., Riely, G. J., et al. (2014) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 57
- Verified
Usability Evaluation of a Mobile Phone–Based System for Remote Monitoring and Management of Chemotherapy-Related Side Effects in Cancer Patients: Mixed-Methods Study
Moradian, S., Krzyzanowska, M. K., Maguire, R., Morita, P. P., Kukreti, V., Avery, J., Liu, G., Cafazzo, J., & Howell, D. (2018) · JMIR Cancer
Mobile Health and mHealth ApplicationsUsability and User Interface Design
Cited by 56
- Verified
TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors
Nagasaka, M., Ohe, Y., Zhou, C., Choi, C.-M., Yang, N., Liu, G., Felip, E., Pérol, M., Besse, B., Nieva, J., et al. (2023) · Future Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 32
- Verified
Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non–small-cell Lung Cancer
Tomasini, P., Mascaux, C., Jao, K., Labbe, C., Kamel-Reid, S., Stockley, T., Hwang, D. M., Leighl, N. B., Liu, G., Bradbury, P. A., et al. (2019) · Clinical Lung Cancer
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 22
- Verified
Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival
Spreafico, A., Coate, L., Zhai, R., Xu, W., Chen, Z.-F., Chen, Z., Patel, D., Tse, B., Brown, M. C., Heist, R. S., et al. (2017) · Cancer Epidemiology
Esophageal Cancer Research and TreatmentHead and Neck Cancer Studies
Cited by 19
- Verified
MA06.03 Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study
Liu, G., Yang, N., Choi, C.-M., Ohe, Y., Sugawara, S., Yanagitani, N., De Braud, F., Nieva, J., Nagasaka, M., Zhou, C., et al. (2024) · Journal of Thoracic Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free